がん生物製剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

• 英文タイトル：Global Cancer Biologics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C1004
• 出版社/出版日：GlobalInfoResearch / 2019年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、121ページ
• 納品方法：Eメール
• 産業分類：Medical Care

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、がん生物製剤の世界市場について調べ、まとめました。種類別セグメントは、モノクローナル抗体、ワクチン、細胞・遺伝子治療、その他等、用途別セグメントは、等に区分しました。がん生物製剤の世界市場概観、企業動向、企業別がん生物製剤シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・がん生物製剤の市場概観
・がん生物製剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・がん生物製剤の企業別販売動向、市場シェア、市場集中度、競争動向
・がん生物製剤の世界市場規模
・がん生物製剤の北米市場分析（アメリカ、カナダ、メキシコ等）
・がん生物製剤のアメリカ市場規模推移
・がん生物製剤のカナダ市場規模推移
・がん生物製剤のメキシコ市場規模推移
・がん生物製剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・がん生物製剤のドイツ市場規模推移
・がん生物製剤のイギリス市場規模推移
・がん生物製剤のロシア市場規模推移
・がん生物製剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・がん生物製剤の日本市場規模推移
・がん生物製剤の中国市場規模推移
・がん生物製剤の韓国市場規模推移
・がん生物製剤のインド市場規模推移
・がん生物製剤の東南アジア市場規模推移
・がん生物製剤の南米市場分析（ブラジル、アルゼンチン等）
・がん生物製剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・がん生物製剤の種類別分析/販売量、売上、市場シェア（モノクローナル抗体、ワクチン、細胞・遺伝子治療、その他）
・がん生物製剤の用途別分析/市場規模（）
・がん生物製剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・がん生物製剤の販売チャネル・代理店・貿易業者・ディーラー分析

Cancer Biologic is a medicinal preparation created by a biological process, it is used to treatment and remission cancer symptoms.

Scope of the Report:
The global Cancer Biologics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Biologics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cancer Biologics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Biologics market by product type and applications/end industries.

Market Segment by Companies, this report covers
Roche
Novartis
Eli Lilly
Sanofi
Celgene
Pfizer
Bayer
Johnson & Johnson
Bristol-Myers Squibb
Merck
Amgen

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Monoclonal Antibodies
Vaccines
Cell and Gene Therapy
Others

Market Segment by Applications, can be divided into
Hospitals
Clinics
Others

レポート目次

Table of Contents

1 Cancer Biologics Market Overview
1.1 Product Overview and Scope of Cancer Biologics
1.2 Classification of Cancer Biologics by Types
1.2.1 Global Cancer Biologics Revenue Comparison by Types (2019-2024)
1.2.2 Global Cancer Biologics Revenue Market Share by Types in 2018
1.2.3 Monoclonal Antibodies
1.2.4 Vaccines
1.2.5 Cell and Gene Therapy
1.2.6 Others
1.3 Global Cancer Biologics Market by Application
1.3.1 Global Cancer Biologics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Cancer Biologics Market by Regions
1.4.1 Global Cancer Biologics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cancer Biologics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Biologics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Biologics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Biologics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Biologics Status and Prospect (2014-2024)
1.5 Global Market Size of Cancer Biologics (2014-2024)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Cancer Biologics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Cancer Biologics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.3 Eli Lilly
2.3.1 Business Overview
2.3.2 Cancer Biologics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Cancer Biologics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Celgene
2.5.1 Business Overview
2.5.2 Cancer Biologics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Celgene Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Cancer Biologics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.7 Bayer
2.7.1 Business Overview
2.7.2 Cancer Biologics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bayer Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.8 Johnson & Johnson
2.8.1 Business Overview
2.8.2 Cancer Biologics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Johnson & Johnson Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.9 Bristol-Myers Squibb
2.9.1 Business Overview
2.9.2 Cancer Biologics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bristol-Myers Squibb Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.10 Merck
2.10.1 Business Overview
2.10.2 Cancer Biologics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Merck Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
2.11 Amgen
2.11.1 Business Overview
2.11.2 Cancer Biologics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Amgen Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cancer Biologics Market Competition, by Players
3.1 Global Cancer Biologics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Biologics Players Market Share
3.2.2 Top 10 Cancer Biologics Players Market Share
3.3 Market Competition Trend
4 Global Cancer Biologics Market Size by Regions
4.1 Global Cancer Biologics Revenue and Market Share by Regions
4.2 North America Cancer Biologics Revenue and Growth Rate (2014-2019)
4.3 Europe Cancer Biologics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cancer Biologics Revenue and Growth Rate (2014-2019)
4.5 South America Cancer Biologics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cancer Biologics Revenue and Growth Rate (2014-2019)
5 North America Cancer Biologics Revenue by Countries
5.1 North America Cancer Biologics Revenue by Countries (2014-2019)
5.2 USA Cancer Biologics Revenue and Growth Rate (2014-2019)
5.3 Canada Cancer Biologics Revenue and Growth Rate (2014-2019)
5.4 Mexico Cancer Biologics Revenue and Growth Rate (2014-2019)
6 Europe Cancer Biologics Revenue by Countries
6.1 Europe Cancer Biologics Revenue by Countries (2014-2019)
6.2 Germany Cancer Biologics Revenue and Growth Rate (2014-2019)
6.3 UK Cancer Biologics Revenue and Growth Rate (2014-2019)
6.4 France Cancer Biologics Revenue and Growth Rate (2014-2019)
6.5 Russia Cancer Biologics Revenue and Growth Rate (2014-2019)
6.6 Italy Cancer Biologics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cancer Biologics Revenue by Countries
7.1 Asia-Pacific Cancer Biologics Revenue by Countries (2014-2019)
7.2 China Cancer Biologics Revenue and Growth Rate (2014-2019)
7.3 Japan Cancer Biologics Revenue and Growth Rate (2014-2019)
7.4 Korea Cancer Biologics Revenue and Growth Rate (2014-2019)
7.5 India Cancer Biologics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cancer Biologics Revenue and Growth Rate (2014-2019)
8 South America Cancer Biologics Revenue by Countries
8.1 South America Cancer Biologics Revenue by Countries (2014-2019)
8.2 Brazil Cancer Biologics Revenue and Growth Rate (2014-2019)
8.3 Argentina Cancer Biologics Revenue and Growth Rate (2014-2019)
8.4 Colombia Cancer Biologics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cancer Biologics by Countries
9.1 Middle East and Africa Cancer Biologics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cancer Biologics Revenue and Growth Rate (2014-2019)
9.3 UAE Cancer Biologics Revenue and Growth Rate (2014-2019)
9.4 Egypt Cancer Biologics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cancer Biologics Revenue and Growth Rate (2014-2019)
9.6 South Africa Cancer Biologics Revenue and Growth Rate (2014-2019)
10 Global Cancer Biologics Market Segment by Type
10.1 Global Cancer Biologics Revenue and Market Share by Type (2014-2019)
10.2 Global Cancer Biologics Market Forecast by Type (2019-2024)
10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)
10.4 Vaccines Revenue Growth Rate (2014-2024)
10.5 Cell and Gene Therapy Revenue Growth Rate (2014-2024)
10.6 Others Revenue Growth Rate (2014-2024)
11 Global Cancer Biologics Market Segment by Application
11.1 Global Cancer Biologics Revenue Market Share by Application (2014-2019)
11.2 Cancer Biologics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Cancer Biologics Market Size Forecast (2019-2024)
12.1 Global Cancer Biologics Market Size Forecast (2019-2024)
12.2 Global Cancer Biologics Market Forecast by Regions (2019-2024)
12.3 North America Cancer Biologics Revenue Market Forecast (2019-2024)
12.4 Europe Cancer Biologics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cancer Biologics Revenue Market Forecast (2019-2024)
12.6 South America Cancer Biologics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cancer Biologics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Cancer Biologics Picture
Table Product Specifications of Cancer Biologics
Table Global Cancer Biologics and Revenue (Million USD) Market Split by Product Type
Figure Global Cancer Biologics Revenue Market Share by Types in 2018
Figure Monoclonal Antibodies Picture
Figure Vaccines Picture
Figure Cell and Gene Therapy Picture
Figure Others Picture
Table Global Cancer Biologics Revenue (Million USD) by Application (2014-2024)
Figure Cancer Biologics Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Cancer Biologics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Cancer Biologics Revenue (Million USD) and Growth Rate (2014-2024)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cancer Biologics Type and Applications
Table Roche Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Cancer Biologics Type and Applications
Table Novartis Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Cancer Biologics Type and Applications
Table Eli Lilly Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Cancer Biologics Type and Applications
Table Sanofi Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Cancer Biologics Type and Applications
Table Celgene Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Cancer Biologics Type and Applications
Table Pfizer Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Cancer Biologics Type and Applications
Table Bayer Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Cancer Biologics Type and Applications
Table Johnson & Johnson Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Cancer Biologics Type and Applications
Table Bristol-Myers Squibb Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Cancer Biologics Type and Applications
Table Merck Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Cancer Biologics Type and Applications
Table Amgen Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Cancer Biologics Revenue (Million USD) by Players (2014-2019)
Table Global Cancer Biologics Revenue Share by Players (2014-2019)
Figure Global Cancer Biologics Revenue Share by Players in 2017
Figure Global Cancer Biologics Revenue Share by Players in 2018
Figure Global Top 5 Players Cancer Biologics Revenue Market Share in 2018
Figure Global Top 10 Players Cancer Biologics Revenue Market Share in 2018
Figure Global Cancer Biologics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Cancer Biologics Revenue (Million USD) by Regions (2014-2019)
Table Global Cancer Biologics Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Biologics Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Biologics Revenue Market Share by Regions in 2018
Figure North America Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure Europe Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure South America Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Cancer Biologics Revenue and Growth Rate (2014-2019)
Table North America Cancer Biologics Revenue by Countries (2014-2019)
Table North America Cancer Biologics Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Biologics Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Biologics Revenue Market Share by Countries in 2018
Figure USA Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure Canada Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure Mexico Cancer Biologics Revenue and Growth Rate (2014-2019)
Table Europe Cancer Biologics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Cancer Biologics Revenue Market Share by Countries (2014-2019)
Figure Europe Cancer Biologics Revenue Market Share by Countries in 2018
Figure Germany Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure UK Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure France Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure Russia Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure Italy Cancer Biologics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Cancer Biologics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Cancer Biologics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Cancer Biologics Revenue Market Share by Countries in 2018
Figure China Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure Japan Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure Korea Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure India Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Cancer Biologics Revenue and Growth Rate (2014-2019)
Table South America Cancer Biologics Revenue by Countries (2014-2019)
Table South America Cancer Biologics Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Biologics Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Biologics Revenue Market Share by Countries in 2018
Figure Brazil Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure Argentina Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure Colombia Cancer Biologics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Cancer Biologics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Cancer Biologics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Biologics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Biologics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure UAE Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure Egypt Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure Nigeria Cancer Biologics Revenue and Growth Rate (2014-2019)
Figure South Africa Cancer Biologics Revenue and Growth Rate (2014-2019)
Table Global Cancer Biologics Revenue (Million USD) by Type (2014-2019)
Table Global Cancer Biologics Revenue Share by Type (2014-2019)
Figure Global Cancer Biologics Revenue Share by Type (2014-2019)
Figure Global Cancer Biologics Revenue Share by Type in 2018
Table Global Cancer Biologics Revenue Forecast by Type (2019-2024)
Figure Global Cancer Biologics Market Share Forecast by Type (2019-2024)
Figure Global Monoclonal Antibodies Revenue Growth Rate (2014-2019)
Figure Global Vaccines Revenue Growth Rate (2014-2019)
Figure Global Cell and Gene Therapy Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Cancer Biologics Revenue by Application (2014-2019)
Table Global Cancer Biologics Revenue Share by Application (2014-2019)
Figure Global Cancer Biologics Revenue Share by Application (2014-2019)
Figure Global Cancer Biologics Revenue Share by Application in 2018
Table Global Cancer Biologics Revenue Forecast by Application (2019-2024)
Figure Global Cancer Biologics Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Cancer Biologics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Cancer Biologics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Cancer Biologics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Cancer Biologics Revenue Market Forecast (2019-2024)
Figure Europe Cancer Biologics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Cancer Biologics Revenue Market Forecast (2019-2024)
Figure South America Cancer Biologics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Cancer Biologics Revenue Market Forecast (2019-2024)

Global GMP Biologics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C2574 2019年7月 121Pages
本調査レポートは、GMPバイオロジクスの世界市場について調べ、まとめました。種類別セグメントは、モノクローナル抗体、ポリクローナル抗体等、用途別セグメントは、等に区分しました。GMPバイオロジクスの世界市場概観、企業動向、企業別GMPバイオロジクスシェア、市場規模推移、市場規模予測（2019年-20...

癌バイオ医薬品の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Cancer Biopharmaceuticals Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C1005 2019年7月 136Pages
本調査レポートは、癌バイオ医薬品の世界市場について調べ、まとめました。種類別セグメントは、生物製剤、バイオシミラー等、用途別セグメントは、等に区分しました。癌バイオ医薬品の世界市場概観、企業動向、企業別癌バイオ医薬品シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨ...

癌免疫療法創薬アウトソーシングの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Cancer Immunotherapy Drug Discovery Outsourcing Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C1007 2019年7月 116Pages
本調査レポートは、癌免疫療法創薬アウトソーシングの世界市場について調べ、まとめました。種類別セグメントは、モノクローナル抗体、免疫調節剤、腫瘍崩壊性ウイルス療法・癌ワクチン、その他等、用途別セグメントは、等に区分しました。癌免疫療法創薬アウトソーシングの世界市場概観、企業動向、企業別癌免疫療法創薬ア...

膵臓癌・胆管癌治療薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Pancreatic and Bile Duct Cancer Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4278 2019年7月 135Pages
本調査レポートは、膵臓癌・胆管癌治療薬の世界市場について調べ、まとめました。種類別セグメントは、血管内皮細胞増殖因子受容体、プログラム細胞死タンパク質1、シグナルトランスデューサー活性化因子3、その他等、用途別セグメントは、等に区分しました。膵臓癌・胆管癌治療薬の世界市場概観、企業動向、企業別膵臓癌...

がん免疫療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Cancer Immunotherapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C1006 2019年7月 117Pages
本調査レポートは、がん免疫療法の世界市場について調べ、まとめました。種類別セグメントは、モノクローナル抗体、免疫チェックポイント阻害剤、免疫システム調節剤、癌ワクチン等、用途別セグメントは、等に区分しました。がん免疫療法の世界市場概観、企業動向、企業別がん免疫療法シェア、市場規模推移、市場規模予測（...

乳がんPARP阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global PARP Inhibitors for Breast Cancer Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4300 2019年8月 104Pages
本調査レポートは、乳がんPARP阻害剤の世界市場について調べ、まとめました。種類別セグメントは、オラパリブ、タラゾパリブ等、用途別セグメントは、携帯電話アクセサリー店、3C小売店、個人等に区分しました。乳がんPARP阻害剤の世界市場概観、企業動向、企業別乳がんPARP阻害剤シェア、市場規模推移、市場...

骨がん治療薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Bone Cancer Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C0880 2019年7月 120Pages
本調査レポートは、骨がん治療薬の世界市場について調べ、まとめました。種類別セグメントは、化学療法、標的療法等、用途別セグメントは、等に区分しました。骨がん治療薬の世界市場概観、企業動向、企業別骨がん治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、ア...

乳がんCDK4 / 6阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global CDK4/6 Inhibitors for Breast Cancer Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C1129 2019年7月 116Pages
本調査レポートは、乳がんCDK4 / 6阻害剤の世界市場について調べ、まとめました。種類別セグメントは、等、用途別セグメントは、子供、大人等に区分しました。乳がんCDK4 / 6阻害剤の世界市場概観、企業動向、企業別乳がんCDK4 / 6阻害剤シェア、市場規模推移、市場規模予測（2019年-2024...

胃癌薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Stomach Cancer Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5533 2019年7月 119Pages
本調査レポートは、胃癌薬の世界市場について調べ、まとめました。種類別セグメントは、化学療法薬、標的療法薬、生物学的療法、その他等、用途別セグメントは、等に区分しました。胃癌薬の世界市場概観、企業動向、企業別胃癌薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロ...

癌用温熱療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Hyperthermia Treatment for Cancer Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C2916 2019年7月 117Pages
本調査レポートは、癌用温熱療法の世界市場について調べ、まとめました。種類別セグメントは、マイクロ波温熱治療器、超音波温熱治療器、赤外線治療器、短波治療器等、用途別セグメントは、等に区分しました。癌用温熱療法の世界市場概観、企業動向、企業別癌用温熱療法シェア、市場規模推移、市場規模予測（2019年-2...

GMPバイオロジクスの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global GMP Biologics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast g…
癌免疫療法創薬アウトソーシングの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Cancer Immunotherapy Drug Discovery Outsourcing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years…
癌バイオ医薬品の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Cancer is a complex invasive genetic disease that causes significant mortality rate worldwide. C…
癌遺伝子治療市場：世界及び中国市場分析・予測（～2024年） Cancer Gene Therapy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cancer Gene Therapy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer Gene Therapy manufactur…
膵臓癌・胆管癌治療薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） It is a drug for treating pancreatic cancer with bile duct cancer. Scope of the Report: Pancreatic cancer is a disease in which malignant (cancer) cells are found in pancreatic tissue. The pancreas is a large gland located in the abdominal cavity and is responsible for the secretion of digestive jui…